Clinical and Translational Allergy20111:5  
Environ Microbiol. 2013 Feb;15(2):334-46.  
Cell Press, Volume 34, Issue 6, p483–495, June 2016  
Curr Med Res Opin. 2014 Jun;30(6):1131-7. doi: 10.1185/03007995.2014.882299. Epub 2014 Jan 30.2:3. Background and objectives: Barrier-enforcing measures have been suggested as treatment options for allergic rhinitis. This review identifies and describes the literature on the subject.
N Engl J Med 2017; 376:2566-78 New article in NEJM supports the role of increased intestinal permeability in the pathophysiology of IBS. 
Italian Journal of Pediatrics 2017, 43(Suppl 1): A2
NOVENTURE will be present at PharmaVenue in Palma de Mallorca. Arrange a meeting with us to learn more about our products and license availability in the different countries.   
We are pleased to announce that we are expanding the international coverage of our products thanks to the recent signature of agreements with both new and loyal partners.  These new partnerships further enable us to spread our global footprint. Soon you will be able to find our products in the following territories: Ukraine - Utipro® Plus (PHARM. FABRIK MONTAVIT GmbH)